questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Azépines
Azépines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Azépines : Questions médicales les plus fréquentes",
"headline": "Azépines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Azépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-14",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Azépines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétéromonocycliques",
"url": "https://questionsmedicales.fr/mesh/D006573",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétéromonocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dilazep",
"alternateName": "Dilazep",
"url": "https://questionsmedicales.fr/mesh/D004109",
"about": {
"@type": "MedicalCondition",
"name": "Dilazep",
"code": {
"@type": "MedicalCode",
"code": "D004109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Meptazinol",
"alternateName": "Meptazinol",
"url": "https://questionsmedicales.fr/mesh/D008621",
"about": {
"@type": "MedicalCondition",
"name": "Meptazinol",
"code": {
"@type": "MedicalCode",
"code": "D008621",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépines",
"alternateName": "Oxazepines",
"url": "https://questionsmedicales.fr/mesh/D010077",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépines",
"code": {
"@type": "MedicalCode",
"code": "D010077",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.498"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pentétrazol",
"alternateName": "Pentylenetetrazole",
"url": "https://questionsmedicales.fr/mesh/D010433",
"about": {
"@type": "MedicalCondition",
"name": "Pentétrazol",
"code": {
"@type": "MedicalCode",
"code": "D010433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.066.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Azépines",
"alternateName": "Azepines",
"code": {
"@type": "MedicalCode",
"code": "D001381",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peng An",
"url": "https://questionsmedicales.fr/author/Peng%20An",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Ranran Li",
"url": "https://questionsmedicales.fr/author/Ranran%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Bin Zhang",
"url": "https://questionsmedicales.fr/author/Bin%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Yi-Kang Zhang",
"url": "https://questionsmedicales.fr/author/Yi-Kang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical Science and Technology, Ynunan University, Kunming, 650500, P. R. China."
}
},
{
"@type": "Person",
"name": "Sylvian Cretton",
"url": "https://questionsmedicales.fr/author/Sylvian%20Cretton",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Azépines",
"item": "https://questionsmedicales.fr/mesh/D001381"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Azépines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Azépines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Azépines",
"description": "Comment diagnostiquer un trouble d'anxiété ?\nQuels tests sont utilisés pour évaluer l'anxiété ?\nLes azépines sont-elles prescrites pour d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nComment différencier l'anxiété normale de l'anxiété pathologique ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Azépines",
"description": "Quels sont les symptômes courants de l'anxiété ?\nLes azépines peuvent-elles provoquer des effets secondaires ?\nComment l'anxiété se manifeste-t-elle physiquement ?\nQuels signes indiquent une crise d'angoisse ?\nLes symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Azépines",
"description": "Comment prévenir les troubles anxieux ?\nLes techniques de relaxation sont-elles efficaces ?\nL'éducation sur l'anxiété peut-elle aider ?\nLe soutien social joue-t-il un rôle dans la prévention ?\nLes azépines peuvent-elles être utilisées en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Azépines",
"description": "Comment les azépines agissent-elles sur l'anxiété ?\nQuels sont les principaux azépines prescrites ?\nLes azépines sont-elles addictives ?\nComment se déroule un traitement avec azépines ?\nLes azépines peuvent-elles être combinées avec d'autres traitements ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Azépines",
"description": "Quelles complications peuvent survenir avec les azépines ?\nLes azépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les risques d'un sevrage brutal ?\nLes azépines peuvent-elles affecter la mémoire ?\nComment gérer les complications liées aux azépines ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Azépines",
"description": "Quels sont les facteurs de risque pour l'anxiété ?\nL'âge influence-t-il le risque d'anxiété ?\nLe sexe joue-t-il un rôle dans l'anxiété ?\nLes antécédents médicaux augmentent-ils le risque ?\nLe mode de vie peut-il influencer l'anxiété ?",
"url": "https://questionsmedicales.fr/mesh/D001381?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble d'anxiété ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes et l'exclusion d'autres troubles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'anxiété ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles d'évaluation psychologique et des entretiens cliniques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les azépines sont-elles prescrites pour d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être utilisées pour les troubles du sommeil et les crises d'angoisse."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la durée des symptômes et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Comment différencier l'anxiété normale de l'anxiété pathologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété pathologique est persistante, excessive et interfère avec le fonctionnement quotidien."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'anxiété ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'inquiétude excessive, l'irritabilité et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles provoquer des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme la somnolence, la confusion et des troubles de la mémoire peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'anxiété se manifeste-t-elle physiquement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des palpitations, des tremblements et des douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une crise d'angoisse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une peur intense, des palpitations, des sueurs et des sensations d'étouffement."
}
},
{
"@type": "Question",
"name": "Les symptômes d'anxiété peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en intensité et en type selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles anxieux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress, l'exercice régulier et une bonne hygiène de vie peuvent aider."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation et le yoga peuvent réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "L'éducation sur l'anxiété peut-elle aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'anxiété et ses mécanismes peut aider à mieux la gérer."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon réseau de soutien social peut réduire le risque de troubles anxieux."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles être utilisées en prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont généralement pas recommandées pour la prévention en raison du risque de dépendance."
}
},
{
"@type": "Question",
"name": "Comment les azépines agissent-elles sur l'anxiété ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent l'effet du GABA, un neurotransmetteur inhibiteur, réduisant ainsi l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux azépines prescrites ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principales incluent le diazépam, le lorazépam et l'alprazolam."
}
},
{
"@type": "Question",
"name": "Les azépines sont-elles addictives ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation prolongée peut entraîner une dépendance et un sevrage difficile."
}
},
{
"@type": "Question",
"name": "Comment se déroule un traitement avec azépines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement commence généralement par une faible dose, ajustée selon la réponse du patient."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles être combinées avec d'autres traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être combinées avec des thérapies cognitivo-comportementales pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les azépines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépendance, le sevrage et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles interagir avec d'autres médicaments ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec des antidépresseurs et des analgésiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'un sevrage brutal ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sevrage brutal peut entraîner des symptômes graves comme des convulsions et des hallucinations."
}
},
{
"@type": "Question",
"name": "Les azépines peuvent-elles affecter la mémoire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des troubles de la mémoire, surtout à forte dose ou sur le long terme."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux azépines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut une réduction progressive de la dose et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'anxiété ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, les antécédents familiaux et des événements traumatiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anxiété ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et les personnes âgées sont souvent plus à risque."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans l'anxiété ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont généralement plus susceptibles de souffrir de troubles anxieux que les hommes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de dépression ou de troubles mentaux augmentent le risque d'anxiété."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il influencer l'anxiété ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....